Literature DB >> 25916907

New naphthoquinone derivatives against glioma cells.

Marco Redaelli1, Carla Mucignat-Caretta1, Abdirisak Ahmed Isse2, Armando Gennaro2, Raffaele Pezzani3, Riccardo Pasquale4, Valeria Pavan4, Marco Crisma5, Giovanni Ribaudo4, Giuseppe Zagotto6.   

Abstract

This work was aimed to the development of a set of new naphtoquinone derivatives that can act against glioma. The compounds were tested in order to find out their ability to inhibit the growth of glioma cells, and the results of these assays were correlated with electrochemical analysis and NMR-based reoxidation kinetic studies, suggesting that a redox mechanism underlies and may explain the observed biological behavior. In addition to a full description of the synthetic pathways, electrochemistry, NMR and single crystal X-ray diffraction data are provided.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Glioma; Naphtoquinones; Redox; Temozolomide

Mesh:

Substances:

Year:  2015        PMID: 25916907     DOI: 10.1016/j.ejmech.2015.04.039

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  The Anti-Glioma Effect of Juglone Derivatives through ROS Generation.

Authors:  Jinsen Zhang; Minjie Fu; Jinfeng Wu; Fengfeng Fan; Xin Zhang; Chunjie Li; Hui Yang; Yonghe Wu; Yiming Yin; Wei Hua
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

2.  Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth.

Authors:  Sheng Zhan; Li Lu; Shu-Shan Pan; Xiao-Qian Wei; Rong-Rong Miao; Xiao-Hui Liu; Ming Xue; Xiu-Kun Lin; Huan-Li Xu
Journal:  Br J Cancer       Date:  2022-04-08       Impact factor: 9.075

3.  The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.

Authors:  Raffaele Pezzani; Beatrice Rubin; Loris Bertazza; Marco Redaelli; Susi Barollo; Halenya Monticelli; Enke Baldini; Caterina Mian; Carla Mucignat; Carla Scaroni; Franco Mantero; Salvatore Ulisse; Maurizio Iacobone; Marco Boscaro
Journal:  Invest New Drugs       Date:  2016-05-14       Impact factor: 3.850

4.  Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II.

Authors:  Huanli Xu; Qunying Chen; Hong Wang; Pingxiang Xu; Ru Yuan; Xiaorong Li; Lu Bai; Ming Xue
Journal:  J Exp Clin Cancer Res       Date:  2016-11-16

5.  Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression.

Authors:  Zeynep Kabakci; Simon Käppeli; Claudio Cantù; Lasse D Jensen; Christiane König; Janine Toggweiler; Christian Gentili; Giovanni Ribaudo; Giuseppe Zagotto; Konrad Basler; Lorenzo A Pinna; Giorgio Cozza; Stefano Ferrari
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.